1
Investors
About
Rejuvenation Technologies develops proprietary therapeutics that use modified mRNA to temporarily activate telomerase and safely lengthen telomeres in human cells, aiming to reverse cellular aging and treat diseases caused by telomere shortening such as pulmonary fibrosis, liver disease, and bone marrow failure.
Explore Rejuvenation Technologies Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.